Invention Grant
- Patent Title: Neisseria meningitidis composition and methods thereof
-
Application No.: US16208347Application Date: 2018-12-03
-
Publication No.: US10550159B2Publication Date: 2020-02-04
- Inventor: Annaliesa Sybil Anderson , Susan Kay Hoiseth , Kathrin Ute Jansen , Justin Keith Moran , Mark E. Ruppen
- Applicant: PFIZER INC.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Anna C. Chau
- Main IPC: A61K39/095
- IPC: A61K39/095 ; C07K14/22
Abstract:
In one aspect, the invention relates to a non-lipidated and non-pyruvylated Neisseria meningitidis serogroup B polypeptide and methods of use thereof. In another aspect, the invention relates to an immunogenic composition including an isolated non-lipidated, non-pyruvylated ORF2086 polypeptide from Neisseria meningitidis serogroup B, and at least one conjugated capsular saccharide from a meningococcal serogroup, and methods of use thereof.
Public/Granted literature
- US20190127426A1 NEISSERIA MENINGITIDIS COMPOSITION AND METHODS THEREOF Public/Granted day:2019-05-02
Information query
